Get In Touch

Apigenin: Market outlook

Apigenin is a yellow crystalline powder that belongs to the flavone class, the aglycone of many glycosides that naturally occurs. It is water-insoluble but soluble in organic solvents. Wide range of pharmacological activities are ascribed to apigenin such as anti-toxicant, anti-inflammatory anti-cancer, etc. Apigenin is a plant extract to diagnose a variety of diseases and inflammatory conditions.

Apigenin is a natural phytochemical present in many vegetables and fruits, but the most common sources are celeriac, chamomile tea, parsley and celery. Apigenin is especially abundant in chamomile plant flowers, accounting for 68% of total flavonoids. Apigenin which are present in the plants are used to treat various diseases including hepatitis, diabetes, cancer arthritis, leishmanial ulcers, dysentery, blennorrhagia, inflammation and haemorrhoids.

Apigenin is a single form of metabolic enzyme inhibiter that inhibits CYP2C9, which is responsible for drug metabolism. Apigenin (5, 7, 4-trihydroxy flavones) is present in very small quantities in the human diet. This composite aspect, such as distribution of bioavailability or excretion in humans. Apigenin is defined as a bioflavonoid of a non-mutagenic nature. Owing to these properties, it is anticipated to boost the growth of Apigenin market is over the forecast period.

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

Growing Interest in Apigenin as a Beneficial and Health-Promoting Agent

Apigenin is one of the most renowned extract among the large range of phenolic compounds, possessing countless nutritional and organoleptic attributes. However, it may also contribute to its beneficial health effects, which may lead to the potential inclusion of nutraceutical formulations. A deeper understanding of apigenin mode of action will be of utmost importance for future nutraceutical applications due to the variety of pharmacological activities and significance to human health.

The different interventions surrounding the potential therapeutic activity of apigenin were researched, such as apoptosis, cell cycle arrest, antioxidant function and anti-inflammatory. It is often believed that apigenin tends to decrease the vascular permeability, which seems to be a defensive strategy against oxidative stress, such as free-radical scavenging.

Apigenin's anti-diabetic properties can be attributed to its ability to increase insulin secretion, inhibit α-glucosidase activity, to interact with and neutralize reactive oxygen species (ROS) in the cell, that together help to prevent diabetic complications. Apigenin has also demonstrated the ability to deliver moderate nitric oxide (NO) to endothelial cells, thereby reducing the risk of endothelial cell damage and hyperglycemic dysfunction.

To gauge the scope of customization in our reports, Ask for a Sample

Increasing Demand for Apigenin Due to its Anticancer Effects to Boost the Market Sales

In general bioactive compounds of plant origin like apigenin, which decreases cancer incidence. High intakes of flavonoids from fruits and vegetables are considered to be inversely associated with the risk of cancer. It was found in the study that there is an inverse correlation between flavonoid intake and incidence of all cancer types, which also provides substantial evidence of a protective effect of flavonoids against lung cancer.

The link between dietary flavonoids and their protective function as well as the reduction of cancer risk was examined, amongst others, in studies on ovarian cancer, breast cancer and the recurring risk of neoplasia with resected patients with colorectal cancer.

Potential chemotherapeutic modality of apigenin in comparison with certain other covalently linked flavonoids despite its low intrinsic toxicity and remarkable effect on normal against cancer cells. Growing demand for apigenin for its anticancer effect is expected to drive the market in the near future.

Global Apigenin: Market Segmentation

On the basis of type, global apigenin can be segmented as:-

  • 0.95
  • 0.98
  • Others

On the basis of Application, global apigenin can be segmented as:-

  • Pharmaceuticals
  • Food Additives
  • Cosmetic and Personal Care
  • Others

Global Apigenin: Key Players

Some of the market participants operating in the global Apigenin market are Monteloeder, Aksuvital, Bo International, Indo Phytochem Pharmaceuticals, Sigma-Aldrich, Selleck, and Indofine Chemical, Shaanxi QingLan Bio-Technology, Shaanxi Pioneer Biotech among others.

Increasing Demand for Apigenin Creating Opportunities for New Players in Apigenin Market

Agricultural yields have contributed to ever-expanding food production. New crop varieties with higher calorie consumption have been and remain to be produced to meet the needs of a rapidly increasing human population, better productivity, more effective food processing, and food aesthetic quality.

The rising prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders, combined with worldwide socioeconomic inequalities, has spurred interest in generating apigenin that can fix the current diabetic scenario at the same time. This has created great opportunities for the manufacturers for enter into this market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Apigenin Market